We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Versarian plc could be a millionaire-maker in 2018

Harvey Jones understands the current excitement about surrounding Versarian plc (LON: VRS) but he also recognises the risks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Advanced materials group Versarien (LSE: VRS) has excited the attentions of investors in recent months after its share price quadrupled from 21p to 80p in just a fortnight. Everybody loves a three-bagger, but the problem is most people love them too late. Does it still have millionaire-maker potential?

The right stuff

My colleague GA Chester made a good job of explaining why Versarien flew to the skies in his recent article. Briefly, in November and early December it announced new partnerships with an unnamed global consumer goods company and US-headquartered global chemicals supplier, plus ongoing advanced negotiations with several multinational companies across various sectors. It is all down to the magic word graphene. 

XXX

Versarien uses proprietary materials technology to create game-changing engineering solutions for blue-chip companies, for use across a broad variety of industry sectors. The quality of its graphene, coupled with its research capabilities in the universities of Manchester and Cambridge, is attracting interest from multinational blue-chips, who are keen to commercialise its developments.

Funds, funds, funds

Versarien also successfully raised £2.9m in November to fund its expansion. The fundraising, which was oversubscribed, was a welcome boost given its dwindling cash balance. This fell from £1.51m on 30 September 2016 to just £350,000 last September.

Versarien recently published a buoyant set of interims, showing group revenues rising 167% to £4.38m, up from £1.64m in the first half of 2016. Its loss before tax almost halved from £1.47m to £770,000. Net assets totalled £5.72m, up slightly from £5.14m in 2016. My worry is that investors are putting a high price on future success with the AIM-listed company’s market cap a pretty meaty £92m. Given that it has been recently making a loss, and was down to its last £350,000, there is a lot of hope built into that valuation. 

Nano technology

The group’s fortunes are also dependent on the success of its own clients. For example, it has a collaboration with CT Engineering in the aerospace industry, which was exposed to the recent decline in the oil and gas sector. This had a knock-on impact on Versarian’s revenues in 2016, which fell from £2.36m to £1.66m as a result. However, with the oil price climbing, its prospects now look brighter.

Versarian recently launched a promising collaboration with Israel Aerospace Industries to supply and test its proprietary Nanene few-layer graphene nano-platelets in aerospace composite structures, and it opened a US sales office in Palo Alto to exploit significant opportunities in the region

Spikey

Versarien is progressing on a number of fronts, and the future looks promising. The share price has dipped slightly following recent excitement as investors take profits and await the next announcement. Currently, it trades at 63p. You could wait for further news before committing funds, but the problem is that if the news is good the share price may spike before you have time to click ‘buy’. It will be riskier buying today, but potentially more rewarding if your nerves can take it.

What really counts right now is commercial opportunities offered by graphene. That is hard for outsiders to judge. Probably one for your watchlist, rather than to dive into today.

Harvey Jones has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »